Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Tebapivat by Agios Pharmaceuticals for Myelodysplastic Syndrome: Likelihood of Approval
Tebapivat is under clinical development by Agios Pharmaceuticals and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase...
Data Insights
Tebapivat by Agios Pharmaceuticals for Sickle Cell Disease: Likelihood of Approval
Tebapivat is under clinical development by Agios Pharmaceuticals and currently in Phase I for Sickle Cell Disease. According to GlobalData,...